Cognitive impairment associated with schizophrenia (CIAS) represents one of the most challenging and debilitating aspects of the disorder, affecting a significant portion of individuals living with schizophrenia. This chronic mental illness is characterized by symptoms such as delusions, hallucinations, and disorganized thinking. However, the cognitive deficits—especially in memory,...

  Schizophrenia continues to challenge patients, caregivers, and clinicians alike with its complex symptoms and chronic nature. But the future of treatment is changing rapidly. Emerging Therapies and Global Efforts in Schizophrenia Care sheds light on the latest advancements in medications, strategies to improve access, and the growing push toward a more holistic and inclusive approach to...

  Schizophrenia is a chronic and debilitating mental disorder characterized by symptoms such as hallucinations, delusions, disorganized thinking, and emotional withdrawal. It significantly impairs an individual's ability to function and affects millions of people worldwide. Despite decades of research, treatment remains challenging due to the disorder's complex nature and varied symptom...

  How Are Antipsychotics Transforming the Schizophrenia Treatment Space?With new medications and delivery systems, antipsychotics are revolutionizing schizophrenia care. These changes are making treatment more accessible, better tolerated, and more effective than ever before. Why Antipsychotics Still Matter Antipsychotics are the backbone of the primary treatment for schizophrenia. They...

    Introduction Human Papillomavirus (HPV) is one of the most prevalent viral infections worldwide, significantly impacting public health. HPV infections are associated with several cancers, including cervical, oropharyngeal, and anogenital cancers, making prevention and treatment a top priority for healthcare systems. With increasing awareness, improved diagnostic tools, and...